TFF PHARMACEUTICALS, INC. Other Income
TFF PHARMACEUTICALS, INC. reported Other Income of $1.00 billion for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-28.
Discontinued › Income Statement › Other Income
us-gaap:OtherIncome · last filed 2024-03-28
- TFF PHARMACEUTICALS, INC. other income for the quarter ending 2022-06-30 was $20.61K, a 95.33% decline year-over-year.
- TFF PHARMACEUTICALS, INC. other income for the quarter ending 2022-03-31 was $57.18K, a 75.28% decline year-over-year.
- TFF PHARMACEUTICALS, INC. other income for the quarter ending 2021-12-31 was $37.02K.
- TFF PHARMACEUTICALS, INC. other income for the quarter ending 2021-09-30 was -$13.13K.
- TFF PHARMACEUTICALS, INC. other income for fiscal 2023 was $1.00B.
- TFF PHARMACEUTICALS, INC. other income for fiscal 2021 was $696.71K.
| Period end | Other Income 0 month | Other Income 3 month | Other Income 6 month | Other Income 9 month | Other Income 12 month |
|---|---|---|---|---|---|
| 2023-12-31 | $1.00B 10-K · filed 2024-03-28 | ||||
| 2022-08-16 | $1.00B 10-K · filed 2023-03-31 | ||||
| 2022-06-30 | $20.61K 10-Q · filed 2022-08-11 | $77.78K 10-Q · filed 2022-08-11 | $114.80K derived: sum of 3 quarters · filed 2023-03-31 | $101.67K derived: sum of 4 quarters · filed 2023-03-31 | |
| 2022-03-31 | $57.18K 10-Q · filed 2022-05-11 | $94.20K derived: sum of 2 quarters · filed 2023-03-31 | $81.07K derived: sum of 3 quarters · filed 2023-03-31 | $522.61K derived: sum of 4 quarters · filed 2023-03-31 | |
| 2021-12-31 | $37.02K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $23.89K derived: sum of 2 quarters · filed 2023-03-31 | $465.44K derived: sum of 3 quarters · filed 2023-03-31 | $696.71K 10-K · filed 2023-03-31 | |
| 2021-09-30 | -$13.13K 10-Q · filed 2022-11-14 | $428.42K derived: sum of 2 quarters · filed 2022-11-14 | $659.70K 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $441.55K 10-Q · filed 2022-08-11 | $672.82K 10-Q · filed 2022-08-11 | |||
| 2021-03-31 | $231.28K 10-Q · filed 2022-05-11 |